Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-03-19
2008-10-21
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S500000
Reexamination Certificate
active
07439237
ABSTRACT:
The present invention relates to the CGRP antagonists of general formulawherein A, X and R1to R3are defined as in claim1, the tautomers, the diastereomers, the enantiomers, the hydrates thereof, the mixtures thereof and the salts thereof and the hydrates of the salts, particularly the physiologically acceptable salts thereof with inorganic or organic acids, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof.
REFERENCES:
patent: 6344449 (2002-02-01), Rudolf et al.
patent: 6521609 (2003-02-01), Doods et al.
patent: 2004/0076587 (2004-04-01), Kruss et al.
patent: 2004/0132716 (2004-07-01), Rudolf et al.
patent: 2004/0192729 (2004-09-01), Rudolf et al.
patent: 2005/0147568 (2005-07-01), Trunk et al.
patent: 2005/0234067 (2005-10-01), Mueller et al.
patent: 2005/0250763 (2005-11-01), Mueller et al.
patent: 2006/0079504 (2006-04-01), Rudolf et al.
patent: 2006/0252750 (2006-11-01), Mueller et al.
patent: 2003276156 (2004-05-01), None
patent: 2387613 (2001-05-01), None
patent: 2503455 (2004-05-01), None
patent: 9811128 (1998-03-01), None
patent: 0018764 (2000-04-01), None
patent: 0110425 (2001-02-01), None
patent: 0132649 (2001-05-01), None
patent: 03070753 (2003-08-01), None
patent: 2004000289 (2003-12-01), None
patent: 2004037810 (2004-05-01), None
patent: 2004037811 (2004-05-01), None
patent: 2004063171 (2004-07-01), None
Brittain, Polymorphism in Pharmaceutical Solids, 1999, pp. 5-8.
Rudolf et al. “Preparation of modified amino acids and their use as calcitonin gene-related peptide antagonists in pharmaceutical compositions” Patent No. WO 9811128, CAPLUS 128:257695 (1998).
Mallee et al. “Receptor activity modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists” Journal of Biological Chemistry 2002; CAPLUS 137:304712.
John J. Mallee et al; Receptor Activity-modifying Protein 1 Determines the Species Selectivity of Non-peptide CGRP Receptor Antagonists; The Journal of Biological Chemistry (Apr. 19, 2002) vol. 277 No. 16 p. 14294-14928; The American Society for Biochemistry and Molecular Biology, Inc.
Arndt Kirsten
Doods Henri
Lustenberger Philipp
Mueller Stephan Georg
Rudolf Klaus
Boehringer Ingelheim International GmbH
Devlin Mary-Ellen M.
Kifle Bruck
Morris Michael P.
Stempel Alan R.
LandOfFree
Selected CGRP-antagonists, process for preparing them and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selected CGRP-antagonists, process for preparing them and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selected CGRP-antagonists, process for preparing them and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4003561